InsidersTradesSigma
Discover the full record of transactions filed by Bashan Dror, Chief Executive Officer. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €94k. Activity tracked since 11 April 2022. The latest transaction was filed on 11 April 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Dror Bashan is the President and CEO of Protalix BioTherapeutics, Inc. He leads the company's operations and strategy, which focuses on developing innovative therapies. Protalix BioTherapeutics is a biopharmaceutical company specializing in gene therapy-based treatments. Bashan's experience in the biopharmaceutical sector is essential for the company's success.